These final results, along with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 guidance the thought of targeting ACKR3 as a novel technique to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated Issues. The website is secure. https://henryh669wiq8.bcbloggers.com/profile